Unaudited Condensed Consolidated Statement of Loss of Immatics N.V.


 
                                Three months ended     Six months ended June 
                                      June 30,          30, 
                              -----------------------  ----------------------- 
                                 2021         2020        2021         2020 
                              -----------  ----------  -----------  ---------- 
                               (Euros in thousands,    (Euros in thousands, 
                                except share and per    except share and per 
                                    share data)         share data) 
Revenue from collaboration 
 agreements                         5,189       6,896       12,592      13,936 
Research and development 
 expenses                        (20,340)    (16,505)     (43,389)    (28,751) 
General and administrative 
 expenses                         (8,271)    (10,076)     (16,702)    (16,264) 
Other income                           26          86          265         200 
Operating result                 (23,396)    (19,599)     (47,234)    (30,879) 
Financial income                      213         437        3,101       1,083 
Financial expenses                  (629)     (2,164)      (1,277)       (110) 
Financial result                    (416)     (1,727)        1,824         973 
Loss before taxes                (23,812)    (21,326)     (45,410)    (29,906) 
Taxes on income                         -           -            -           - 
Net loss                         (23,812)    (21,326)     (45,410)    (29,906) 
Attributable to: 
Equity holders of 
 the parent                      (23,812)    (21,043)     (45,410)    (29,349) 
Non-controlling interest                -       (283)            -       (557) 
Net loss                         (23,812)    (21,326)     (45,410)    (29,906) 
                              ===========  ==========  ===========  ========== 
Net loss per share 
 - basic and diluted               (0.38)      (0.64)       (0.72)      (0.89) 
Weighted average 
 shares outstanding 
 - basic and diluted           62,909,095  33,093,838   62,908,945  33,093,838 
 

Unaudited Condensed Consolidated Statement of Comprehensive Loss of Immatics N.V.


 
                                                        Three months ended June 
                                                                  30,              Six months ended June 30, 
                                                        ------------------------   --------------------------- 
                                                          2021         2020        2021            2020 
                                                        ---------      ---------   ---------       ----------- 
                                                          (Euros in thousands)     (Euros in thousands) 
Net Loss                                                 (23,812)       (21,326)    (45,410)        (29,906) 
Other comprehensive loss 
Items that may be reclassified subsequently to profit 
 or loss, net of tax                                            -              -           -                 - 
Currency translation differences from foreign 
 operations                                               (1,401)            791       1,324                99 
Total comprehensive loss for the period                  (25,213)       (20,535)    (44,086)          (29,807) 
 
Attributable to: 
Equity holders of the parent                             (25,213)       (20,252)    (44,086)          (29,250) 
Non-controlling interest                                        -          (283)           -             (557) 
Total comprehensive loss for the period                  (25,213)       (20,535)    (44,086)          (29,807) 
                                                        =========      =========   =========       =========== 
 
 

Unaudited Condensed Consolidated Statement of Cash Flows of Immatics N.V.


 
                                               Six months ended June 
                                                30, 
                                               ----------------------- 
                                                  2021         2020 
                                               -----------  ---------- 
                                               (Euros in thousands) 
 
Cash flows from operating activities 
Loss before taxation                              (45,410)    (29,906) 
Adjustments for: 
Interest income                                       (87)       (755) 
Depreciation and amortization                        2,264       2,288 
Interest expense                                       140         110 
Equity settled share-based payment                  16,270       6,928 
MD Anderson compensation expense                         -          45 
Increase in other liabilities resulting 
 from share appreciation rights                          -       7,773 
Cash-out related to share-based compensation 
 previously classified as equity-settled                 -     (4,322) 
Net foreign exchange differences                       236           1 
Changes in working capital 
Decrease in accounts receivable                        532         530 
Decrease/(increase) in other assets                    902     (1,106) 
Increase in accounts payable and other 
 current liabilities                              (11,363)     (9,724) 
Interest received                                       54         510 
Interest paid                                        (140)       (110) 
Net cash used in operating activities             (36,602)    (27,738) 
                                               -----------  ---------- 
Cash flows from investing activities 
Payments for property, plant and equipment         (1,912)     (4,514) 
Cash paid for investments classified 
 in Other financial assets                        (53,782)    (32,859) 
Cash received from maturity of investments 
 classified in Other financial assets               45,770      48,881 
Payments for intangible assets                       (390)        (36) 
Proceeds from disposal of property, 
 plant and equipment                                     8           - 
Net cash (used in)/provided by investing 
 activities                                       (10,306)      11,472 
                                               -----------  ---------- 
Cash flows from financing activities 
Payments for leases                                (1,348)     (1,168) 
Net cash used in financing activities              (1,348)     (1,168) 
                                               -----------  ---------- 
Net decrease in cash and cash equivalents         (48,256)    (17,434) 
                                               ===========  ========== 
Cash and cash equivalents at beginning 
 of period                                         207,530     103,353 
                                               ===========  ========== 
Effects of exchange rate changes on 
 cash and cash equivalents                             819         137 
Cash and cash equivalents at end of 
 period                                            160,093      86,056 
                                               ===========  ========== 
 

Unaudited Condensed Consolidated Statement of Changes in Shareholders' equity (deficit) of Immatics N.V.


 
                                                                                                                                                                                   Total 
                                                                                                                                                                               share-holders' 
                                                                Share    Share    Accumulated  Other     Total equity (deficit) attributable to shareholders  Non-controlling      equity 
(Euros in thousands)                                            capital  premium  deficit      reserves  of the parent                                           interest        (deficit) 
                                                                                  -----------  --------  ---------------------------------------------------  ---------------  -------------- 
Balance as of January 1, 2020                                     1,164  190,945    (233,194)     (770)                                             (41,855)            1,020        (40,835) 
Other comprehensive loss                                              -        -            -        99                                                   99                -              99 
Net loss                                                              -        -     (29,349)         -                                             (29,349)            (557)        (29,906) 
Comprehensive loss for the year                                       -        -     (29,349)        99                                             (29,250)            (557)        (29,807) 
Equity-settled share-based compensation                               -    6,928            -         -                                                6,928                -           6,928 
Cash-out related to share-based compensation previously 
classified as equity-settled                                          -  (4,322)            -         -                                              (4,322)                -         (4,322) 
MD Anderson milestone compensation expense                            -        -            -         -                                                    -               45              45 
                                                                -------  -------  -----------  --------  ---------------------------------------------------  ---------------  -------------- 

(MORE TO FOLLOW) Dow Jones Newswires

August 10, 2021 07:00 ET (11:00 GMT)